MarketInOut Stock Screener Log In | Sign Up
 

Laboratorios Farmaceuticos Rovi S.A.

VIE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 05/22/2026
Laboratorios Farmaceuticos Rovi S.A. stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeVIE
Market Capitalization3,209.63 mln
Float16.30 mln
Earnings Date05/08/2026

EPS

2.37
Solid

P / E

25.02
Elevated

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.43
Borderline

Relative Strength

10 / 100
Significantly lagging

Debt / Equity

0.17
Very low leverage

Business Description

Founded in 1946 and based near Madrid, Laboratorios Farmacéuticos Rovi is a Spanish pharmaceutical company that produces and sells a wide range of medicines across Europe and beyond. The company markets treatments covering areas such as heart health, bone and joint care, pain management, respiratory conditions, and several others, distributing both prescription drugs and specialist hospital products. Rovi also runs a significant contract manufacturing operation, handling everything from sterile filling and packaging to the assembly of injectable products like prefilled syringes and vials for third-party clients. It operates as part of the Norbel Inversiones group and continues to develop new drug candidates to grow its portfolio.

Key Fundamentals

EPS2.37
P/E25.02
ROE14.56
RPS10.22
ROIC12.64
ROA10.10
Interest Cover51.94
EBITDA, mln140
EV / EBITDA23.16
EV / EBIT27.73
Revenue, mln523
EV / Revenue6.20

Financial Strength

Altman Z-Score10.71
Piotroski F-Score 6 / 9
Beneish M-Score-2.43
Price to Intrinsic Value1.89
Price to Lynch Fair Value1.95
Price to Graham Number2.58
Shiller PE Ratio28.65

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.34% 36 / 100   
1 Month -30.94% 0 / 100   
2 Months -23.53% 5 / 100   
6 Months 1.81% 40 / 100   
1 Year 17.22% 58 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us